80 related articles for article (PubMed ID: 24110733)
1. Expression of c-erbB-2 in breast cancer cell lines as experimental receptor of magnetic nanoparticles.
Silva JG; Sánchez V; Polo SM; González CA
Annu Int Conf IEEE Eng Med Biol Soc; 2013; 2013():4498-501. PubMed ID: 24110733
[TBL] [Abstract][Full Text] [Related]
2. c-erbB-2 as a possible target for the use of magnetic nanoparticles in breast cancer cells.
Silva-Escobedo JG; Sanchez-Monroy V; Rojas-Lopez M; Lopez-Cruz J; González CA
IEEE Trans Nanobioscience; 2014 Sep; 13(3):300-7. PubMed ID: 25014961
[TBL] [Abstract][Full Text] [Related]
3. An intracellular anti-erbB-2 single-chain antibody is specifically cytotoxic to human breast carcinoma cells overexpressing erbB-2.
Wright M; Grim J; Deshane J; Kim M; Strong TV; Siegal GP; Curiel DT
Gene Ther; 1997 Apr; 4(4):317-22. PubMed ID: 9176517
[TBL] [Abstract][Full Text] [Related]
4. A biosensor capable of identifying low quantities of breast cancer cells by electrical impedance spectroscopy.
Huerta-Nuñez LFE; Gutierrez-Iglesias G; Martinez-Cuazitl A; Mata-Miranda MM; Alvarez-Jiménez VD; Sánchez-Monroy V; Golberg A; González-Díaz CA
Sci Rep; 2019 Apr; 9(1):6419. PubMed ID: 31015522
[TBL] [Abstract][Full Text] [Related]
5. Breast Cancer Tissue Marked Selectively by Magnetic Nanoparticles in an Experimental Animal Model.
Silva JG; Lopez J; Sánchez V; Lozano LM; González CA
J Nanosci Nanotechnol; 2015 Dec; 15(12):9591-6. PubMed ID: 26682383
[TBL] [Abstract][Full Text] [Related]
6. MCF-7 breast cancer cells overexpressing transfected c-erbB-2 have an in vitro growth advantage in estrogen-depleted conditions and reduced estrogen-dependence and tamoxifen-sensitivity in vivo.
Liu Y; el-Ashry D; Chen D; Ding IY; Kern FG
Breast Cancer Res Treat; 1995 May; 34(2):97-117. PubMed ID: 7647336
[TBL] [Abstract][Full Text] [Related]
7. Antitumoral actions of the anti-obesity drug orlistat (XenicalTM) in breast cancer cells: blockade of cell cycle progression, promotion of apoptotic cell death and PEA3-mediated transcriptional repression of Her2/neu (erbB-2) oncogene.
Menendez JA; Vellon L; Lupu R
Ann Oncol; 2005 Aug; 16(8):1253-67. PubMed ID: 15870086
[TBL] [Abstract][Full Text] [Related]
8. Selection of potentially metastatic subpopulations expressing c-erbB-2 from breast cancer tissue by use of an extravasation model.
Roetger A; Merschjann A; Dittmar T; Jackisch C; Barnekow A; Brandt B
Am J Pathol; 1998 Dec; 153(6):1797-806. PubMed ID: 9846970
[TBL] [Abstract][Full Text] [Related]
9. A light-controllable specific drug delivery nanoplatform for targeted bimodal imaging-guided photothermal/chemo synergistic cancer therapy.
Guo Y; Wang XY; Chen YL; Liu FQ; Tan MX; Ao M; Yu JH; Ran HT; Wang ZX
Acta Biomater; 2018 Oct; 80():308-326. PubMed ID: 30240955
[TBL] [Abstract][Full Text] [Related]
10. AKT3 regulates ErbB2, ErbB3 and estrogen receptor α expression and contributes to endocrine therapy resistance of ErbB2(+) breast tumor cells from Balb-neuT mice.
Grabinski N; Möllmann K; Milde-Langosch K; Müller V; Schumacher U; Brandt B; Pantel K; Jücker M
Cell Signal; 2014 May; 26(5):1021-9. PubMed ID: 24463007
[TBL] [Abstract][Full Text] [Related]
11. Effectiveness of an adriamycin immunoconjugate that recognizes the C-erbB-2 product on breast cancer cell lines.
Jinno H; Ueda M; Enomoto K; Ikeda T; Kyriakos P; Kitajima M
Surg Today; 1996; 26(7):501-7. PubMed ID: 8840431
[TBL] [Abstract][Full Text] [Related]
12. Targeted Herceptin-dextran iron oxide nanoparticles for noninvasive imaging of HER2/neu receptors using MRI.
Chen TJ; Cheng TH; Chen CY; Hsu SC; Cheng TL; Liu GC; Wang YM
J Biol Inorg Chem; 2009 Feb; 14(2):253-60. PubMed ID: 18975017
[TBL] [Abstract][Full Text] [Related]
13. Bidirectional interactions between the estrogen receptor and the cerbB-2 signaling pathways: heregulin inhibits estrogenic effects in breast cancer cells.
Grunt TW; Saceda M; Martin MB; Lupu R; Dittrich E; Krupitza G; Harant H; Huber H; Dittrich C
Int J Cancer; 1995 Nov; 63(4):560-7. PubMed ID: 7591267
[TBL] [Abstract][Full Text] [Related]
14. [Effects of magnetic c-erbB-2 antisense probe of different concentrations on morphology and expression of SK-Br-3 cancer cell lines in vitro].
Liu HY; Wen ZP; Wen M; He HR; Tan SD; Li SL
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2013 Feb; 35(1):19-23. PubMed ID: 23469785
[TBL] [Abstract][Full Text] [Related]
15. Magnetite nanoparticle-loaded anti-HER2 immunoliposomes for combination of antibody therapy with hyperthermia.
Ito A; Kuga Y; Honda H; Kikkawa H; Horiuchi A; Watanabe Y; Kobayashi T
Cancer Lett; 2004 Aug; 212(2):167-75. PubMed ID: 15279897
[TBL] [Abstract][Full Text] [Related]
16. Sensitivity analysis of electrical bioimpedance patterns of breast cancer cells labeled with magnetic nanoparticles: forming the foundation for a biosensor of circulating tumor cells.
González-Díaz CA; Golberg A
Physiol Meas; 2020 Jul; 41(6):064001. PubMed ID: 32413882
[TBL] [Abstract][Full Text] [Related]
17. Involvement of nuclear steroid/thyroid/retinoid receptors and of protein kinases in the regulation of growth and of c-erbB and retinoic acid receptor expression in MCF-7 breast cancer cells.
Schneider SM; Offterdinger M; Huber H; Grunt TW
Breast Cancer Res Treat; 1999 Nov; 58(2):171-81. PubMed ID: 10674883
[TBL] [Abstract][Full Text] [Related]
18. Tyrosine kinase inhibitors as modulators of trastuzumab-mediated antibody-dependent cell-mediated cytotoxicity in breast cancer cell lines.
Collins DM; Gately K; Hughes C; Edwards C; Davies A; Madden SF; O'Byrne KJ; O'Donovan N; Crown J
Cell Immunol; 2017 Sep; 319():35-42. PubMed ID: 28735814
[TBL] [Abstract][Full Text] [Related]
19. Synthesis, characterization and in vitro evaluation of exquisite targeting SPIONs-PEG-HER in HER2+ human breast cancer cells.
Almaki JH; Nasiri R; Idris A; Majid FA; Salouti M; Wong TS; Dabagh S; Marvibaigi M; Amini N
Nanotechnology; 2016 Mar; 27(10):105601. PubMed ID: 26861770
[TBL] [Abstract][Full Text] [Related]
20. Adenovirus-mediated overexpression of dominant negative epidermal growth factor receptor-CD533 as a gene therapeutic approach radiosensitizes human carcinoma and malignant glioma cells.
Lammering G; Lin PS; Contessa JN; Hampton JL; Valerie K; Schmidt-Ullrich RK
Int J Radiat Oncol Biol Phys; 2001 Nov; 51(3):775-84. PubMed ID: 11697324
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
